The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.
about
Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brainDiabetes mellitus and cognitive impairmentsAmyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's diseaseProtein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitusMagnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer's modelInsulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease.Pioglitazone ameliorates Aβ42 deposition in rats with diet-induced insulin resistance associated with AKT/GSK3β activationIntranasal Insulin Improves Age-Related Cognitive Deficits and Reverses Electrophysiological Correlates of Brain AgingDPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal CellsBrain insulin resistance deteriorates cognition by altering the topological features of brain networks.Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases.The Effects of LW-AFC on the Hippocampal Transcriptome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology.The diabetic brain and cognition.Oligomerization of a Glucagon-like Peptide 1 Analog: Bridging Experiment and Simulations.Exendin-4 protects Aβ(1-42) oligomer-induced PC12 cell apoptosis.Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's disease.The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain.SIRT3 activator Honokiol attenuates β-Amyloid by modulating amyloidogenic pathway.Perspectives in Lipocalin-2: Emerging Biomarker for Medical Diagnosis and Prognosis for Alzheimer's Disease.Reduction of Cognitive Decline in Patients with or at High Risk for Diabetes.Therapeutic implications of how TNF links APOE, P-tau, α-synuclein, β-amyloid, and insulin resistance in neurodegenerative diseases
P2860
Q27003253-7A22D5B5-8F1C-46DC-86B5-0C2755D8445BQ28079459-12A96A90-E977-4240-960D-52454FB3B4C7Q28384947-D97290E4-3777-4458-BFDB-CAF7BFCDA2CAQ28397425-6473401B-39DF-4D4A-96DB-6AE18842EF28Q28543427-D34A9DF1-89E9-480B-9F0A-93CC7E5B0765Q33628048-F42D3D20-3620-4FFC-A881-2EE1B167E74DQ33674777-A06320C8-2D2C-41E9-A7B0-286648EA875BQ36444567-EAF63788-2ACC-42D8-83B6-DBF1F69F4B28Q37275631-CC0D6373-C5AA-42B4-8AE4-1A2F5C8FEA56Q37538874-5F31DFBA-A436-4344-A840-45B43BD19BF4Q38668948-67894B10-8777-4152-992B-F088BDA7F1F3Q38949860-F8B61E8E-C8D8-4B31-8288-D0D5EA0807A5Q38974881-A0DEBAB5-9D59-463A-A91C-EEDBDEB7BD60Q40098573-A89181B6-FBB3-438A-8910-87B7AC1CB764Q40572806-D77FDC34-E1A8-4BBD-A16D-F5CC3C8E20A0Q41003546-1A23F1D8-8A18-4F70-A8B6-2E218DA15C72Q46058400-B25B02AA-68D4-418C-BA80-36B285AF1FFAQ47111896-73B93672-41A1-4D2D-A768-8C0EB1161DF5Q48043496-8AC6E4BF-D5C0-4BED-AC17-9F3DE4F8DBA9Q49165016-C08D96E5-C95A-48A7-B1F8-E60F0A6E6015Q49687656-995A392F-BD62-4868-8ADA-412524B87C17Q56344227-CD8DB6A0-4425-4F69-97B5-F76655289518
P2860
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The nature, significance, and ...... stance in Alzheimer's disease.
@ast
The nature, significance, and ...... stance in Alzheimer's disease.
@en
type
label
The nature, significance, and ...... stance in Alzheimer's disease.
@ast
The nature, significance, and ...... stance in Alzheimer's disease.
@en
prefLabel
The nature, significance, and ...... stance in Alzheimer's disease.
@ast
The nature, significance, and ...... stance in Alzheimer's disease.
@en
P2860
P1476
The nature, significance, and ...... stance in Alzheimer's disease.
@en
P2093
Hoau-Yan Wang
Konrad Talbot
P2860
P304
P356
10.1016/J.JALZ.2013.12.007
P433
P577
2014-02-01T00:00:00Z